Freedman B I, Iskandar S S, Appel R G
Department of Medicine, Bowman Gray School of Medicine, Winston-Salem, NC 27157-1053.
Am J Kidney Dis. 1995 Feb;25(2):207-21. doi: 10.1016/0272-6386(95)90001-2.
Nephrosclerosis is literally defined as hardening of the kidneys (Greek derivation: nephros, kidney; sklerosis, hardening). It is the result of scarring or replacement of the normal renal parenchyma by dense collagenous tissue. In practice, nephrosclerosis refers to diseases with predominant pathologic changes occurring in the preglomerular microvasculature and secondarily involving the glomeruli and interstitium. The relationship between mild to moderate hypertension and either nephrosclerosis or end-stage renal disease (ESRD) remains circumstantial, although these syndromes have long been associated in the medical literature. Nephrologists credit hypertension as the etiology of nephrosclerosis in 25% of patients initiating Medicare-supported renal replacement therapy, even though other processes may cause similar renal pathologic findings. Strikingly, serum creatinine values infrequently increase in patients with long-standing mild to moderate hypertension. Patients classified as having hypertensive ESRD typically present with advanced disease, making the processes that initiated the renal disease difficult to detect. Nephrologists are twice as likely to label an African-American patient as having hypertensive nephrosclerosis, compared with a white patient, when presented with identical clinical histories. This review proposes that many patients classified as having hypertensive nephrosclerosis actually have intrinsic renal parenchymal diseases, renal artery stenosis, unrecognized episodes of accelerated hypertension, or a primary renal microvascular disease. The familial clustering of ESRD attributed to hypertension in African-Americans and the identification of genes associated with renal injury in animals support the concept that inherited factors may predispose to renal failure. African-American families often have members with ESRD from disparate etiologies, including hypertensive ESRD. This suggests that common mechanisms, be they inherited or environmental, underlie the development of progressive renal failure in diverse forms of nephropathy. Identification of the mechanisms producing susceptibility to progressive renal disease would support the concept that mild to moderate elevations in blood pressure per se are uncommon causes of nephrosclerosis.
肾硬化从字面上定义为肾脏的硬化(源自希腊语:nephros,肾脏;sklerosis,硬化)。它是正常肾实质被致密胶原组织瘢痕化或替代的结果。在实际应用中,肾硬化指的是主要病理变化发生在肾小球前微血管系统,继而累及肾小球和间质的疾病。尽管在医学文献中,轻度至中度高血压与肾硬化或终末期肾病(ESRD)长期以来一直相关,但它们之间的关系仍不明确。肾病学家认为,在开始接受医疗保险支持的肾脏替代治疗的患者中,25%的肾硬化病因是高血压,尽管其他过程也可能导致类似的肾脏病理表现。令人惊讶的是,长期患有轻度至中度高血压的患者血清肌酐值很少升高。被归类为高血压性ESRD的患者通常表现为晚期疾病,这使得引发肾病的过程难以察觉。当面对相同的临床病史时,肾病学家将非裔美国患者诊断为高血压性肾硬化的可能性是白人患者的两倍。本综述提出,许多被归类为高血压性肾硬化的患者实际上患有原发性肾实质疾病、肾动脉狭窄、未被识别的恶性高血压发作或原发性肾微血管疾病。非裔美国人中归因于高血压的ESRD家族聚集现象以及在动物中鉴定出与肾损伤相关的基因,支持了遗传因素可能易患肾衰竭的概念。非裔美国家庭中常有来自不同病因(包括高血压性ESRD)的ESRD患者。这表明,无论是遗传还是环境因素,共同机制是多种形式肾病中进行性肾衰竭发展的基础。确定导致对进行性肾病易感性的机制将支持血压轻度至中度升高本身并非肾硬化常见病因这一观点。